| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -9.09M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, SLN returned +148.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +118.6% |
| 1 year | +148.4% |
| 5 years | -42.5% |
| All-time high | $27.46 (May 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in SLN would be worth today ›No. Silence Therapeutics plc has not paid a dividend in the past 12 months.
Silence Therapeutics plc stock trades on NASDAQ under the ticker symbol SLN.
Silence Therapeutics plc is part of the Healthcare sector.
Silence Therapeutics plc has a market cap of 826.03M USD, based on the latest quote.
Silence Therapeutics plc is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
